<?xml version="1.0" encoding="UTF-8"?>
<p>Pre‐treatment blood tests could be completed locally, either via the GP or at local hospitals, to save patient travel and footfall in the trial site, with results sent to the site for review before carfilzomib dosing. Monthly follow‐up visits were permissible via telephone or video conferencing, initiating in‐person assessment and/or investigations as clinically indicated.</p>
